Dashboard
Manage Tickers

XFOR X4 Pharmaceuticals, Inc

Nasdaq x4pharma.com


$ 2.99 $ -0.09 (-2.94 %)    

Tuesday, 14-Oct-2025 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 2.97
$ 3.01
$ 2.90 x 300
$ 3.06 x 1,400
$ 2.91 - $ 3.03
$ 1.35 - $ 26.83
377,733
na
33.88M
$ 1.33
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 03-25-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 03-21-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 03-21-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-17-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-03-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 03-19-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-04-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 03-12-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
26 05-15-2019 03-31-2019 10-Q
27 03-11-2019 12-31-2018 10-K
28 11-09-2018 09-30-2018 10-Q
29 08-13-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 03-09-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

x4-pharmaceuticals-announces-strategic-restructuring-with-50-workforce-reduction-expected-to-deliver-13m-annualized-cost-savings
X4 Pharmaceuticals Announces Strategic Res...
09/17/2025 11:12:37

Organizational restructuring including a 50% reduction in workforce that is anticipated to result in annualized cost savings of...

stifel-maintains-buy-on-x4-pharmaceuticals-lowers-price-target-to-9
Stifel Maintains Buy on X4 Pharmaceuticals...
08/29/2025 13:13:31

Stifel analyst Stephen Willey maintains X4 Pharmaceuticals (NASDAQ:XFOR) with a Buy and lowers the price target from $30 to $9.

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/19/2025 17:06:05

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
08/18/2025 21:06:13

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/13/2025 12:08:29

hc-wainwright--co-maintains-buy-on-x4-pharmaceuticals-lowers-price-target-to-35
HC Wainwright & Co. Maintains Buy on X4 Ph...
08/13/2025 11:55:47

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains X4 Pharmaceuticals (NASDAQ:XFOR) with a Buy and lowers the ...

trading-halt-halt-status-updated-at-72500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:25:...
08/13/2025 11:25:04

trading-halt-halted-at-33744-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 3:37:44 p.m. ET - ...
08/12/2025 19:37:49

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/12/2025 17:07:02

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/12/2025 12:08:34

x4-pharmaceuticals-secures-60m-private-placement-in-public-equity-financing-with-significant-management-and-board-changes
X4 Pharmaceuticals Secures $60M Private Pl...
08/12/2025 11:21:23

x4-pharmaceuticals-president-and-ceo-paula-ragan-and-cfo-adam-mostafa-have-stepped-down-from-their-respective-roles-x4-board-of-directors-has-appointed-adam-craig-as-executive-chair-john-volpone-as-president-and-david-kirske-as-cfo-effectively-immediately
X4 Pharmaceuticals' President And CEO Paul...
08/12/2025 11:16:47

x4-pharmaceuticals-announced-private-placement-in-public-equity-financing-of-approximately-60m
X4 Pharmaceuticals Announced Private Place...
08/12/2025 11:14:15

$60 million PIPE financing led by Coastlands Capital, Bain Capital Life Sciences and New Enterprise AssociatesNewly appointed b...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
07/28/2025 17:06:06

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/24/2025 21:06:08

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/24/2025 17:06:06

x4-pharmaceuticals-enters-purchase-agreement-with-lincoln-park-can-sell-up-to-40m-in-stock
X4 Pharmaceuticals Enters Purchase Agreeme...
06/23/2025 20:41:12

https://www.sec.gov/ix?doc=/Archives/edgar/data/1501697/000162828025032627/xfor-20250623.htm

x4-pharmaceuticals-highlights-presentation-of-phase-2-chronic-neutropenia-trial-data-at-30th-annual-congress-of-the-european-hematology-association
X4 Pharmaceuticals Highlights Presentation...
06/16/2025 12:05:18

x4-pharmaceuticals-granted-fda-fast-track-designation-for-mavorixafor-f0r-chronic-neutropenia
X4 Pharmaceuticals Granted FDA Fast Track ...
06/10/2025 12:04:26

hc-wainwright--co-maintains-buy-on-x4-pharmaceuticals-raises-price-target-to-7
HC Wainwright & Co. Maintains Buy on X4 Ph...
05/02/2025 12:47:30

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains X4 Pharmaceuticals (NASDAQ:XFOR) with a Buy and raises the ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION